Michael Thomas Henderson, Chief Business Officer at BridgeBio Pharma, Inc. (BBIO), sold 20,000 shares at $51.12 ($1.0M) on 2020-12-01, disclosed to the SEC on 2020-12-02.
Open-market sale of $1.0M BBIO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.12 | 3,028 | $155K | 15.0% |
| 2 | $51.12 | 3,028 | $155K | 15.0% |
| 3 | $51.69 | 6,972 | $360K | 35.0% |
| 4 | $51.69 | 6,972 | $360K | 35.0% |
| Total | $51.52 avg | 20,000 | $1.0M | 100% |
| Filing → |
| SYRE | SELL | 2026-06-23 | $2.0M | — | Filing → |
| APGE | SELL | 2026-06-12 | $1.7M | — | Filing → |
| APGE | SELL | 2026-05-15 | $1.6M | — | Filing → |